Mayer Fishman, M.D., Ph.D.
H. Lee Moffitt Cancer Center and Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Mayer Fishman, M.D., Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:22 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01373294 · Oral Lenalidomide and Intravesical BCG for Therapy of Bladder CancerH. Lee Moffitt Cancer Center and Research Institute · completed · Bladder Cancer · principal investigator
- N/ANCT00694551 · PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive TreatmentH. Lee Moffitt Cancer Center and Research Institute · completed · Prostate Cancer · principal investigator
- Ph2NCT00100906 · Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell CancerH. Lee Moffitt Cancer Center and Research Institute · completed · Kidney Cancer · principal investigator
- Ph2NCT00006371 · A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate CancerH. Lee Moffitt Cancer Center and Research Institute · terminated · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.